Deal Capsule - October 2017 | KPMG | DE
Share with your friends

Deal Capsule - October 2017

Deal Capsule - October 2017

M&A activity remains solid in life sciences.



Partner, Head of Chemicals & Pharmaceuticals

KPMG AG Wirtschaftsprüfungsgesellschaft


Related content


Theme of this issue:

M&A activity remains solid in life sciences with a high number of announced deals, although deal values are not expected to hit the heady levels of 2014 and 2015. Oncology drives M&A in life sciences as key players seek to optimize their portfolios in anticipation of 10.9% CAGR growth to 2030. Chemical companies are increasingly focussing their M&A on application industries. Agrochemicals remains an M&A hotspot. The closing of the DowDuPont merger brought with it a spate of anti-trust divestments. US and China remain the most active countries in both sectors.

Online version

Browse directly through the publication

KPMG Deal Capsule Newsletter

Connect with us


Request for proposal